Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Minimal Reduction of PU.1 Is Sufficient to Induce a Preleukemic State and Promote Development of Acute Myeloid Leukemia

Britta Will, PhD, Thomas O. Vogler, Swathi-rao Narayanagari, Boris Bartholdy, Tihomira I. Todorova, MSc, Jiahao Chen, Yiting Yu, Jillian Mayer, Mariana da Silva Ferreira, Laura Barreyro, PhD, Luis Carvajal, Michael Roth, MD, Johanna van Oers, Sonja Schaetzlein, Christine McMahon, MD, Winifried Edelmann, Amit Verma, MD, Ulrich Steidl, MDPhD

Blood (2015) 126 (23): 305.

https://doi.org/10.1182/blood.V126.23.305.305

Published: 2015

Journal Articles

Polycythemia Vera Vs. Secondary Erythrocytosis Mortality Outcome in a Multiracial Inner City Cohort

Jose Nahun Galeas, MD, Yiting Yu, Rahul Polineni, MD, Vineeth Sukrithan, MD, Cosmin Tegla, MD, Amit Verma, MD, Swati Goel, MBBS

Blood (2015) 126 (23): 5183.

https://doi.org/10.1182/blood.V126.23.5183.5183

Published: 2015

Journal Articles

PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome

Ashley Pandolfi, Robert F. Stanley, Yiting Yu, Boris Bartholdy, Gopichand Pendurti, Kira Gritsman, Jacqueline Boultwood, Jonathan Chernoff, Amit Verma, Ulrich Steidl

Blood (2015) 126 (9): 1118–1127.

https://doi.org/10.1182/blood-2014-12-618801

Published: 2015

Includes: Supplemental data

Journal Articles

IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells

Carolina Schinke, Orsolya Giricz, Weijuan Li, Aditi Shastri, Shanisha Gordon, Laura Barreyro, Tushar Bhagat, Sanchari Bhattacharyya, Nandini Ramachandra, Matthias Bartenstein, Andrea Pellagatti, Jacqueline Boultwood, Amittha Wickrema, Yiting Yu, Britta Will, Sheng Wei, Ulrich Steidl, Amit Verma

Blood (2015) 125 (20): 3144–3152.

https://doi.org/10.1182/blood-2015-01-621631

Published: 2015

Includes: Supplemental data

Journal Articles

Myelodysplastic Syndrome Marrow Stroma Shows Widespread Aberrant Hypermethylation That Is Abrogated By Treatment with Dnmt Inhibitors

Tushar D Bhagat, PhD, Matthias Bartenstein, MD, Yiting Yu, PhD, A. Mario Q. Marcondes, MD PhD, Britta Will, PhD, Orsolya Giricz, PhD, Davendra P. Sohal, MD MPH, Ioannis Mantzaris, MD, Amittha Wickrema, PhD, Christine Mcmahon, MD, Yeung Cecilia, MD, John Greally, MB, PhD, Siddhartha Mukherjee, MD PhD, Ulrich Steidl, MD PhD, H. Joachim Deeg, MD, Amit Verma, MD

Blood (2014) 124 (21): 4379.

https://doi.org/10.1182/blood.V124.21.4379.4379

Published: 2014

Journal Articles

PAK1 Is a Therapeutic Target in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Robert Stanley, Ashley Pandolfi, M.Sc., Amit Verma, MD, Ulrich Steidl, MD PhD, Jonathan Chernoff, MD PhD, Yiting Yu, PhD, Jacqueline Boultwood

Blood (2014) 124 (21): 4614.

https://doi.org/10.1182/blood.V124.21.4614.4614

Published: 2014

Journal Articles

Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine

Aditi Shastri, MD, Carolina Schinke, MD, Asya Varshavsky Yanovsky, MD PhD, Tushar D. Bhagat, PhD, Orsolya Giricz, Laura Barreyro, M.Sc., Jacqueline Boultwood, PhD, Andrea Pellagati, Yiting Yu, PhD, Jennifer R. Brown, MD PhD, David A. Frank, MD PhD, Bhaskar Das, PhD, Suman Kambhampati, MD, Britta Will, PhD, Ulrich Steidl, MDPhD, Amit Verma, MD

Blood (2014) 124 (21): 3602.

https://doi.org/10.1182/blood.V124.21.3602.3602

Published: 2014

Journal Articles

Outcomes and Treatment Patterns of Patients with CML in an Inner-City, Underserved, Multi-Ethnic Patient Cohort Reveals Good Overall Survival with Both First and Second Generation TKIs As Initial Therapy

Amer Assal, MD, Ramadevi Medavarapu, MD, Ellen W Friedman, MD, Yiting Yu, PhD, Amit Verma, MD, Olga Derman, MD

Blood (2014) 124 (21): 5522.

https://doi.org/10.1182/blood.V124.21.5522.5522

Published: 2014

Journal Articles

Sites of Extranodal Involvement Are Prognostic in Patients with Stage 1 Follicular Lymphoma: An Analysis of the Surveillance, Epidemiology and End Results Database

Aditi Shastri, MD, Yiting Yu, PhD, Amit Verma, MD, Stefan Klaus Barta, MDMRCP,MS

Blood (2014) 124 (21): 1670.

https://doi.org/10.1182/blood.V124.21.1670.1670

Published: 2014

Journal Articles

Association Between Downregulation of POT1 Expression and Chromosome 7 Deletion, Response to Hypomethylation Agent Treatment, and Patient Survival in Myelodysplastic Syndromes

Yue Wei, Amit Verma, MD, Monica Cabrero, MD, Yu Jia, Hong Zheng, Zhihong Fang, Yiting Yu, PhD, Simona Colla, Zach Bohannan, Teresa V. Bowman, PhD, Jacqueline Boultwood, PhD, Guillermo Garcia-Manero, MD

Blood (2014) 124 (21): 4663.

https://doi.org/10.1182/blood.V124.21.4663.4663

Published: 2014

Journal Articles

Ethnicity Specific Cutoffs for Neutropenia Are Predictive of Overall Survival in a Large Elderly Cohort: An Analysis of 26,652 Individuals

Ioannis Mantzaris, MD, Pavlos Msaouel, MD PhD, Anthony P. Lam, MD MHS, Ellen W Friedman, MD, Yiting Yu, PhD, Amit Verma, MD

Blood (2014) 124 (21): 4944.

https://doi.org/10.1182/blood.V124.21.4944.4944

Published: 2014

Journal Articles

Efficacy of Dual Inhibition of p38 Mitogen Activated Protein Kinase (MAPK) and Tie-2 Kinase in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Blood (2014) 124 (21): 4628.

https://doi.org/10.1182/blood.V124.21.4628.4628

Published: 2014

Journal Articles

Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects

Timothy Geoffrey Bowler, PhD MBBS, Matthias Bartenstein, MD, Kerry A. Morrone, MD, Mersedeh Rohanizadegan, MD, Rachel M. Kessel, MD, Lauren Hooda, Ishan Datt, Orsolya Giricz, PhD, Tushar D. Bhagat, PhD, Bartlomiej P Przychodzen, Simrit Parmar, Jonathan B. Gill, MD, Yiting Yu, PhD, Jaroslaw P. Maciejewski, MD PhD, Ulrich Steidl, MDPhD, Amit Verma, MD

Blood (2014) 124 (21): 4591.

https://doi.org/10.1182/blood.V124.21.4591.4591

Published: 2014

Journal Articles

Anisocytosis Is Associated With Decreased Survival In Patients With Newly Diagnosed Myelodysplastic Syndromes: A Single Center Experience

Ashwin Sridharan, MD, Rishi Jain, MD, Marcus Bachhuber, MD, Anthony P. Lam, MD, MHS, Yiting Yu, Ph.D, Ellen W. Friedman, MD, Amit Verma, MD

Blood (2013) 122 (21): 5218.

https://doi.org/10.1182/blood.V122.21.5218.5218

Published: 2013

Journal Articles

Inhibition Of CXCR2 As a Therapeutic Strategy In AML and MDS

Carolina Schinke, Orsolya Giricz, Shanisha A. K. Gordon, Laura Barreyro, M.Sc., Tushar D. Bhagat, Andrea Pellagatti, Jacqueline Boultwood, Yiting Yu, Ulrich Steidl, MD PhD, Amit Verma

Blood (2013) 122 (21): 484.

https://doi.org/10.1182/blood.V122.21.484.484

Published: 2013

Journal Articles

miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling

Blood (2013) 121 (15): 2875–2881.

https://doi.org/10.1182/blood-2011-12-397067

Published: 2013

Includes: Supplemental data

Journal Articles

The Independent Effect of Platelet Count On Mortality in a Large Inner City Elderly Outpatient Population

Pavlos Msaouel, MD, PhD, Anthony P. Lam, MD, MHS, Krishna Gundabolu, MD, Grigorios Chrysofakis, M.D., Yiting Yu, PhD, Ellen W. Friedman, MD, Amit Verma, MD

Blood (2012) 120 (21): 4645.

https://doi.org/10.1182/blood.V120.21.4645.4645

Published: 2012

Journal Articles

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes

Sriram Sundaravel, MS, Tushar D. Bhagat, MS, Carolina Schinke, M.D., David Ebenezer, Hui Liu, MS, Yiting Yu, PhD, Andrea Pellagatti, PhD, Jacqueline Boultwood, MD, Vijay Yajnik, MD, Ph.D, Andrew Artz, MD MS, Amit Verma, Amittha Wickrema, PhD

Blood (2012) 120 (21): 924.

https://doi.org/10.1182/blood.V120.21.924.924

Published: 2012

Journal Articles

Multiplicative Interaction Between Mean Corpuscular Volume and Red Cell Distribution Width in Predicting Mortality of Elderly Patients with and without Anemia

Anthony P. Lam, MD, MHS, Krishna Gundabolu, MD, Ashwin Sridharan, MD, Rishi Jain, MD, Pavlos Msaouel, MD, PhD, Grigorios Chrysofakis, M.D., Yiting Yu, PhD, Ellen W. Friedman, MD, Elizabeth Price, MD, MPH, Stanley L. Schrier, MD, Amit Verma, MD

Blood (2012) 120 (21): 5150.

https://doi.org/10.1182/blood.V120.21.5150.5150

Published: 2012

Journal Articles

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

Blood (2012) 120 (10): 2076–2086.

https://doi.org/10.1182/blood-2011-12-399683

Published: 2012

Includes: Supplemental data

NARROW

Minimal Reduction of PU.1 Is Sufficient to Induce a Preleukemic State and Promote Development of Acute Myeloid Leukemia

Polycythemia Vera Vs. Secondary Erythrocytosis Mortality Outcome in a Multiracial Inner City Cohort

PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome

IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells

Myelodysplastic Syndrome Marrow Stroma Shows Widespread Aberrant Hypermethylation That Is Abrogated By Treatment with Dnmt Inhibitors

PAK1 Is a Therapeutic Target in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine

Outcomes and Treatment Patterns of Patients with CML in an Inner-City, Underserved, Multi-Ethnic Patient Cohort Reveals Good Overall Survival with Both First and Second Generation TKIs As Initial Therapy

Sites of Extranodal Involvement Are Prognostic in Patients with Stage 1 Follicular Lymphoma: An Analysis of the Surveillance, Epidemiology and End Results Database

Association Between Downregulation of POT1 Expression and Chromosome 7 Deletion, Response to Hypomethylation Agent Treatment, and Patient Survival in Myelodysplastic Syndromes

Ethnicity Specific Cutoffs for Neutropenia Are Predictive of Overall Survival in a Large Elderly Cohort: An Analysis of 26,652 Individuals

Efficacy of Dual Inhibition of p38 Mitogen Activated Protein Kinase (MAPK) and Tie-2 Kinase in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects

Anisocytosis Is Associated With Decreased Survival In Patients With Newly Diagnosed Myelodysplastic Syndromes: A Single Center Experience

Inhibition Of CXCR2 As a Therapeutic Strategy In AML and MDS

miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling

The Independent Effect of Platelet Count On Mortality in a Large Inner City Elderly Outpatient Population

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes

Multiplicative Interaction Between Mean Corpuscular Volume and Red Cell Distribution Width in Predicting Mortality of Elderly Patients with and without Anemia

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only